Abstract: Systems and methods for monitoring blood flow metrics using a patch of a flexible substrate configured to attach to an area of skin over a blood vessel. The patch includes a plurality of light sources arranged on the substrate to form a matrix and a row of photodetectors disposed on the substrate substantially in parallel with the rows of LEDs. The patch includes an optical signal interface configured to drive each light source and to input an intensity signal at one of the photodetectors. The intensity signals are used to determine AC and DC components corresponding to each optical path. AC to DC component ratios are calculated for each optical path and used to determine ratio-of-ratio values. At least a subset of the ratio-of-ratio values are used to determine a biological metric or a cross-sectional area of the blood vessel.

Abstract: Systems and methods for monitoring blood flow metrics using a patch of a flexible substrate configured to attach to an area of skin over a blood vessel. The patch includes a plurality of light sources arranged on the substrate to form a matrix and a row of photodetectors disposed on the substrate substantially in parallel with the rows of LEDs. The patch includes an optical signal interface configured to drive each light source and to input an intensity signal at one of the photodetectors. The intensity signals are used to determine AC and DC components corresponding to each optical path. AC to DC component ratios are calculated for each optical path and used to determine ratio-of-ratio values. At least a subset of the ratio-of-ratio values are used to determine a biological metric or a cross-sectional area of the blood vessel.

Abstract: An electrostatic precipitator may have different collecting and repelling electrodes surfaces. For example, a collecting electrode may have an internal conductive portion. A non-conductive or less conductive open cell foam covering may be applied to the conductive core of the collecting electrode. The foam may have cell sizes that vary within the volume of the foam or along the length of the foam. Accordingly the cell size of the foam near the leading, with respect to the direction of airflow, portion of the collector may be larger than the cell size of the foam nearer the trailing end of the collector and/or the cell size of the foam near the exterior of the collector may be larger than the cell size of the foam nearer to the interior of the collector.

Abstract: An electrostatic precipitator may have a set of collector electrodes and a set of repelling electrodes. The conductive portions of the collector electrodes and/or the repelling may be arranged in segments. The segments may have differing electrical properties or may be electrically isolated to facilitate differing potentials along an airflow path. The differing potentials results in differing electric field strengths along the airflow path.

Abstract: An electrostatic precipitator may have a set of collector electrodes and a set of repelling electrodes. The conductive portions of the collector electrodes and/or the repelling may be arranged in segments. The segments may have differing electrical properties or may be electrically isolated to facilitate differing potentials along an airflow path. The differing potentials results in differing electric field strengths along the airflow path.

Abstract: An electrostatic precipitator may have different collecting and repelling electrodes surfaces. For example, a collecting electrode may have an internal conductive portion. A non-conductive or less conductive open cell foam covering may be applied to the conductive core of the collecting electrode. The foam may have cell sizes that vary within the volume of the foam or along the length of the foam. Accordingly the cell size of the foam near the leading, with respect to the direction of airflow, portion of the collector may be larger than the cell size of the foam nearer the trailing end of the collector and/or the cell size of the foam near the exterior of the collector may be larger than the cell size of the foam nearer to the interior of the collector.

Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.

Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.